Alice Crane, MD
Transplant Surgery · Kansas City, MONPI 1790101160
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations.
Across 10 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$40
- Teva Pharmaceuticals USA, Inc.$30
- Eurofins Viracor, LLC$26
- UCB, Inc.$24
- Merck$19
- Medtronic$17
- plus $31 from 2 others
What the payments were for
- Food & beverage$186100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Eurofins Viracor, LLC | 1 | $26 |
| UCB, Inc. | 1 | $24 |
| Merck | 1 | $19 |
| Medtronic | 1 | $17 |
| Ambu Inc. | 1 | $16 |
| 180 Medical, Inc. | 1 | $14 |
How this compares
Too few transplant surgery providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 29 | $15,657 |
| Tamsulosin Hcl | 94 | $1,234 |
| Oxybutynin Chloride ErOxybutynin Chloride | 45 | $775 |
| Solifenacin Succinate | 21 | $397 |
| Finasteride | 27 | $272 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Kansas City
- Matthew WilkinsonKansas City$9K
- Henry RandallKansas City$2K
- Clark BonhamKansas City$212
- Daniel MurilloKansas City$172
- Eddie IslandKansas City$103
- Jason WellenSaint Louis$617K
- William ChapmanSaint Louis$8K
- Harvey SolomonSaint Louis$6K
- Jesse DavidsonSaint Louis$4K
- Surendra ShenoySaint Louis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.